A vs UTHR · P/E 29, rev $1.88B vs P/E 20, rev $2.88B
Agilent Technologies Inc (A) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Agilent Technologies Inc (A) is a diagnostics & research company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported A revenue for 2026-07-31 was $1.88B. Net income was $362.0M. Revenue was up 2.3% from 2026-04-30 to 2026-07-31. A currently screens at market cap $33.70B and trailing P/E 29.2.
Latest reported UTHR revenue for 2024-12-31 was $2.88B. Net income was $1.20B. Revenue was up 23.6% from 2023-12-31 to 2024-12-31. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
A currently screens at market cap $33.70B and trailing P/E 29.2. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the A and UTHR stock pages for the full models.
Not investment advice.